Vermillion Receives Notice of Allowance for Patent on Methods for Diagnosing Ovarian Cancer

Vermillion, Inc. VRML has received a notice of allowance from the United States Patent and Trademark Office for a patent, "Methods for Diagnosing Ovarian Cancer." This patent further expands the list of biomarkers Vermillion has employed in the diagnosis or status determination of ovarian cancer. In this case, the granted claims cover the use of Protein C Inhibitor in ovarian cancer tests using blood and several other sample types.